Pfizer

Pfizer CEO discusses why the third booster jab isn't enough to protect people against Covid in the long run, thus a fourth booster is needed.

The FDA's Center for Biologics Evaluation and Research (CBER) has released the data from Pfizer's clinical trials.

With only 34% of SA youth vaccinated, the Department of Health are discussing alternatives to save the Pfizer doses before expiring.

SA health regulator, Sahpra has also approved the mixing and matching of the Johnson & Johnson vaccine with the Pfizer vaccine.

After initially being approved in March 2021, Pfizer has officially received the green light from SAHPRA to administer a third vaccine dose.

SAHPRA will commence with assessing the data regarding the safety and efficacy of the third Pfizer dose against Covid-19.

Pfizer announced that they are working on a new easy-to-take antiviral drug in the hopes that it will prevent the spreading of Covid-19.

In relation to a new global vaccine trial for children and adolescents, SAPHRA has approved the Pfizer vaccine for children age 12 and up.